VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Operating income, 2025
- −$393M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$393M | — |
| 2024 | −$151M | — |
| 2023 | −$101M | — |
| 2022 | −$70M | — |
| 2021 | −$56M | — |
| 2020 | −$43M | — |
| 2019 | −$33M | — |
| 2018 | −$26M | — |
| 2017 | −$19M | — |
| 2016 | −$14M | — |
| 2015 | −$12M | — |
| 2014 | −$23M | — |